z-logo
open-access-imgOpen Access
Lung Manifestation of Collagen Vascular Disease in HRCT
Author(s) -
Jagruti Kalola,
Anjana Trivedi,
Hiral Happani,
Mohit Chauhan
Publication year - 2020
Publication title -
asian journal of medical radiological research
Language(s) - English
Resource type - Journals
eISSN - 2347-338X
pISSN - 2347-3371
DOI - 10.47009/ajmrr.2020.8.1.2
Subject(s) - medicine , honeycombing , bronchiectasis , interstitial lung disease , connective tissue , lung , high resolution computed tomography , connective tissue disease , restrictive lung disease , pathology , pulmonary fibrosis , fibrosis , extrinsic allergic alveolitis , connective tissue disorder , airway , radiology , disease , surgery , autoimmune disease
Background: The aim of this paper was to evaluate the thoracic manifestations associated with the Connective tissue disorders, with an emphasis on interstitial and airway disease pattern on the High Resolution computed tomography (HRCT) findings. Subjects and Methods: The present study was conducted for a period of one year. A total of 50 patients with various connective tissue disorders having respiratory complaints were evaluated. Results:  During the study period 50 patients (80%females and 20%males) underwent evaluation. Cough and dyspnea were  the most common presenting symptoms. Variety of thoracic abnormalities weredetected in 67 (95%) cases. Most common abnormality detected on HRCT was interstitial fibrosis/interstitial lung disease present in (60%) cases. Most common parenchymal abnormalities seen were reticulations (61.4%), ground glass opacification (40%), mosaic attenuation (32.8%) and honeycombing (24.3%). Airway abnormalities seen were bronchiectasis (48.5%), emphysema (12.8%), and ground glass nodules (2.8%). Conclusion: Interstitial lung disease is the most common pulmonary manifestation among patients with connective tissue disorders, and early detection and prompt treatment is expected to improve the outcome.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here